U.S. Central Venous Catheter Market – Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdown in various countries across the globe has impacted the financial status of businesses across all sectors. The private healthcare sector is one such sector, which has been majorly impacted by the pandemic. COVID-19 has also affected the economies in three main ways- by directly affecting the production and demand, by creating disruptions in distribution channels, and through its financial impact on companies and financial markets. The increase in central-line–associated bloodstream infections and blood culture contamination rates increase the market growth. For instance, in November 2020, National Center for Biotechnology Information published a report which reported that a there was a significant increase in central-line–associated bloodstream infections and blood culture contamination rates during the pandemic. Blood culture contamination rates were 19% higher during the COVID-19 period, whereas the CLABSI (central-line–associated bloodstream infections) rate during the pandemic increased by 25% in US.
Thus, impact of the Coronavirus (COVID-19) pandemic had driven the growth of the U.S. central venous catheter market during the pandemic.
U.S. central venous catheter market is estimated to be valued at USD 1,142.4 Mn in 2024 and is expected to exhibit a CAGR of 6.2% during the forecast period (2024-2031).
Figure 1. U.S. Central Venous Catheter Market Value (USD Mn), by Product Type, 2024
Increasing number of advantages associated with single lumen is expected to drive the growth of U.S. central venous catheter market
Increasing advantages associated with single lumen drives the growth of U.S. central venous catheter market over the forecast period. For example:
Market Trends
Increasing use of peripherally inserted central catheters is expected to bolster the U.S. central venous catheter market growth over the forecast period. Increasing use of peripherally inserted central catheters associated with low complications is expected to drive the growth of U.S. central venous catheter market over the forecast period. For instance, in May 2021, Journal of Medicine and Life, a peer-reviewed open access journal, published a report which stated that PICCs (peripherally inserted central catheters) may be used as a safe option for central venous access in children either in the intermediate- or long-term. New types of PICC may facilitate broader indications and provide longer dwell times. PICC placement can be learned easily, usually requires light sedation and/or local anesthesia, and seldom causes serious perioperative risks. Application of assisted visualization and having well-educated staff could improve the insertion success rate and reduce the complications of PICCs.
U.S. Central Venous Catheter Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients